Literature DB >> 1390825

Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation.

B J Keller1, D S Marsman, J A Popp, R G Thurman.   

Abstract

A number of plasticizers and lipid-lowering drugs induce peroxisomes and cause hepatocellular carcinoma in rodents by mechanisms which remain unknown. In this study, seven structurally dissimilar peroxisome proliferating agents were shown to uncouple oxidative phosphorylation in isolated rat liver mitochondria. For example, perfluorooctanoate (0.5 mM) increased succinate-induced (state 4) mitochondrial respiration by over 50% while stimulation of state 3 respiration with ADP was minimal (i.e., uncoupling occurred). Interestingly, compounds which are potent carcinogens in vivo (e.g., Wy-14,643 and perfluorooctanoate) were more powerful uncouplers of oxidative phosphorylation in vitro than weak tumor-causing agents (e.g., valproate). Uncoupling also occurred in vivo. Basal rates of oxygen uptake in perfused livers from chronically treated rats were increased from 137 +/- 7 mumol g-1/h in pair-fed controls to 153 +/- 5 mumol g-1/h after 2.5 months of feeding Wy-14,643 (0.1% w/v in diet). Concomitantly, rates of urea synthesis from ammonia, a process highly dependent on ATP supply, were reduced almost completely from 104 +/- 10 mumol g-1/h to 13 +/- 6 mumol g-1/h. Bile flow, another energy-dependent process, was also reduced significantly by treatment with Wy-14,643 in vivo for 24 h. Taken together, these data indicate that energy supply for cellular processes such as urea synthesis and bile flow was disrupted in vivo due to uncoupling of oxidative phosphorylation by Wy-14,643. It is proposed that peroxisomal proliferators accumulate in the liver where they uncouple mitochondrial oxidative phosphorylation and interfere with cellular energetics.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390825     DOI: 10.1016/0005-2728(92)90105-b

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Effect of contaminants of emerging concern on liver mitochondrial function in Chinook salmon.

Authors:  Andrew Yeh; David J Marcinek; James P Meador; Evan P Gallagher
Journal:  Aquat Toxicol       Date:  2017-06-16       Impact factor: 4.964

2.  Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects.

Authors:  Mitchell B Rosen; Judith R Schmid; J Christopher Corton; Robert D Zehr; Kaberi P Das; Barbara D Abbott; Christopher Lau
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

3.  Chronic treatment with the peroxisome proliferator-activated receptor alpha agonist Wy-14,643 attenuates myocardial respiratory capacity and contractile function.

Authors:  Makhosazane Zungu; Martin E Young; William C Stanley; M Faadiel Essop
Journal:  Mol Cell Biochem       Date:  2009-04-10       Impact factor: 3.396

Review 4.  PPARs and the cardiovascular system.

Authors:  Milton Hamblin; Lin Chang; Yanbo Fan; Jifeng Zhang; Y Eugene Chen
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

5.  1H NMR-Based Metabolomic Analysis of Sub-Lethal Perfluorooctane Sulfonate Exposure to the Earthworm, Eisenia fetida, in Soil.

Authors:  Brian P Lankadurai; Vasile I Furdui; Eric J Reiner; André J Simpson; Myrna J Simpson
Journal:  Metabolites       Date:  2013-08-27

6.  Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors.

Authors:  Geary W Olsen; Timothy R Church; John P Miller; Jean M Burris; Kristen J Hansen; James K Lundberg; John B Armitage; Ross M Herron; Zahra Medhdizadehkashi; John B Nobiletti; E Mary O'Neill; Jeffrey H Mandel; Larry R Zobel
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

7.  Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma.

Authors:  A Senff-Ribeiro; A Echevarria; E F Silva; C R C Franco; S S Veiga; M B M Oliveira
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.